← Dihexa overview

Dihexa Dosage & Reconstitution Guide

⚠ Zero human trials exist. Its potency in cell models is the marketing line, but potency without human safety data cuts both ways.

Research and educational use only — not medical advice, and not for human consumption. The figures below are summarized from public sources, product labeling, and community reports, and are not a prescription or a substitute for a qualified clinician.

Typical dose
5-20 mg
Route
Oral / sublingual
Frequency
once daily or split

Dosing guide

Level Dose Notes
Conservative start 5 mg daily
Common range 10 mg daily
Upper reports 20 mg daily — least precedent

Timing & cycling

Oral or sublingual, with fat (it is lipophilic); morning dosing suits its activating profile.

Cycle length. Community blocks run 2–6 weeks with breaks; nobody has data supporting continuous use.

Storage & handling

Store capsules or powder in a cool, dry, dark place, tightly closed. Follow the product's own expiry date.

Key points

  • An angiotensin IV-derived HGF/c-Met potentiator from Washington State University's lab work.
  • The c-Met pathway is also a cancer-proliferation pathway — the theoretical concern that keeps cautious users at low doses and short blocks.

What to monitor

Cognitive endpoints are subjective; journal your baseline before starting or you will not be able to tell.

Legal & prescription status

No legal prescription exists. It is an unapproved research chemical, sold only for laboratory research and labelled 'not for human consumption.' It is not FDA-approved for any human use.

References

  1. doi.org
  2. doi.org
  3. pubmed.ncbi.nlm.nih.gov
  4. doi.org
  5. doi.org
  6. doi.org

This guide is for research and educational purposes only. It is not medical advice and does not describe a product approved for human use. Always consult a qualified healthcare professional before considering any peptide protocol.